# Laboratory Validation for Hereditary Tyrosinemia 1 \(HT1\)

> Contract award record from UK public-sector procurement sources.

## Key facts

- Public buyer: [NHS england](/buyers/nhs-england/contract-awards)
- Contract winner: NHS GREATER GLASGOW AND CLYDE
- Award value: £26,523
- Tender value: £26,523
- Award date: 25 March 2024
- Published: 23 April 2024
- Contract start: 1 February 2024
- Contract end: 31 July 2024
- Stage: awarded
- Procurement category: services
- Notice ID: 67eb0867-a8e2-4069-b6d7-b69868a7fd20-743369
- OCID: ocds-b5fd17-11dd918e-85f7-485e-8c89-0172acae95ca

## Description

Stage 1 of Hereditary Tyrosinaemia 1 implementation: Laboratory validation and verification of non-derivatised MSMS kits for use when screening for HT1 using succinylacetone measurement in dried blood spot samples in 3 laboratories\.

## Related contract awards

- [D&A Platform Run & Maintain](/contracts/ocds-b5fd17-58fe109d-49a3-4eea-957d-31f6bd69ff81): NHS England
- [IT Operations Centre](/contracts/ocds-b5fd17-e780baf5-a211-4ca2-a85a-9925bd8fd863): NHS England
- [Inquiry E Disclosure Platform](/contracts/ocds-b5fd17-521ee39b-0c8c-4aa6-aaf3-0c4c876df72a): NHS England

## Source

[View the original notice on Contracts Finder](https://www.contractsfinder.service.gov.uk/Notice/67eb0867-a8e2-4069-b6d7-b69868a7fd20-743369)